Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade

Journal of Neuroscience Research

Volumn 70, Issue 3, 2002, Pages 274-282

  Kihara, Takeshi ^a   Shimohama, Shun ^a   Sawada, Hideyuki ^a   Honda, Kazuhiro ^a   Nakamizo, Tomoki ^a   Kanki, Rie ^a   Yamashita, Hiroshi ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cortical neurons; Dopamine D2 agonists; Phosphatidylinositol 3 kinase cascade

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BROMOCRIPTINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; NEUROTRANSMITTER; NITRIC OXIDE; PEROXYNITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; QUINPIROLE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG MECHANISM; FETUS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALZHEIMER DISEASE; ANIMALS; BROMOCRIPTINE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOPAMINE AGONISTS; ENZYME INHIBITORS; FETUS; GLUTAMIC ACID; IONOPHORES; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE DONORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINPIROLE; RATS; RECEPTORS, DOPAMINE D2; UP-REGULATION;

EID: 0037010305     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10426     Document Type: Article

References (42)

1. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 94:3627-3632.
2. Akaike A, Tamura Y, Yokota T, Shimohama S, Kimura J. 1994. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644:181-187.
3. Beal MF. 1992. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119-130.
4. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. 1991. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
5. Choi DW, Rothman SM. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171-182.
6. Downward J. 1998. Ras signalling and apoptosis. Curr Opin Genet Dev 8:49-54.
7. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo LM, Roher AE. 1996. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021-6037.
8. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5:101-106.
9. Harris EW, Ganong AH, Cotman CW. 1984. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res 323:132-137.
10. Jackson DM, Westlind-Danielsson A. 1994. Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-370.
11. Jia WW, Wang Y, Qiang D, Tufaro F, Remington R, Cynader M. 1996. A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult. Brain Res Mol Brain Res 42:350-353.
12. Joyce JN, Kaeger C, Ryoo H, Goldsmith S. 1993. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 154:171-174.
13. Joyce JN, Myers AJ, Gurevich E. 1998. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Res 784:7-17.
14. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. 1997. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42:159-163.
15. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, Akaike A. 1998. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792:331-334.
16. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A. 2001. Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276:13541-13546.
17. Landwehrmeyer B, Mengod G, Palacios JM. 1993a. Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18:187-192.
18. Landwehrmeyer B, Mengod G, Palacios JM. 1993b. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145-153.
19. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM. 1996. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 16:486-496.
20. Liu XH, Kato H, Chen T, Kato K, Itoyama Y. 1995. Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J Neurol Sci 129:9-14.
21. Luo Y, Kokkonen GC, Wang X, Neve KA, Roth GS. 1998. D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/J NK pathways in rat C6-D2L glioma cells. J Neurochem 71:980-990.
22. Meredith MJ, Cusick CL, Soltaninassab S, Sekhar KS, Lu S, Freeman ML. 1998. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem Biophys Res Commun 248:458-463.
23. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol Rev 78:189-225.
24. Nishibayashi S, Asanuma M, Kohno M, Gomez-Vargas M, Ogawa N. 1996. Scavenging effects of dopamine agonists on nitric oxide radicals. J Neurochem 67:2208-2211.
25. Ogawa N, Tanaka K, Asanuma M, Kawai M, Masumizu T, Kohno M, Mori A. 1994. Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Res 657:207-213.
26. O'Malley KL, Harmon S, Tang L, Todd RD. 1992. The rat dopamine D4 receptor: Sequence, gene structure, and demonstration of express ion in the cardiovascular system. New Biol 4:137-146.
27. O'Neill MJ, Hicks CA, Ward MA, Cardwell GP, Reymann JM, Allain H, Bentue-Ferrer D. 1998. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur J Pharmacol 352:37-46.
28. Pettmann B, Henderson CE. 1998. Neuronal cell death. Neuron 20:633-647.
29. 123I]-IBZM. Neurology 47:1065-1068.
30. +) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. J Neurosci Res 43:55-62.
31. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Kimura J, Shimohama S. 1998. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress. Ann Neurol 44:110-119.
32. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. 1986. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem 46:288-293.
33. Shimohama S, Ogawa N, Tamura Y, Akaike A, Tsukahara T, Iwata H, Kimura J. 1993. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res 632:296-302.
34. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B. 1997. Transformation of hematopoietic cells by BCR/ABL requires activation o f a PI3k/Akt-dependent pathway. EMBO J 16:6151-6161.
35. Struck LK, Rodnitzky RL, Dobson JK. 1990. Stroke and its modification in Parkinson's disease. Stroke 21:1395-1399.
36. Tyurin VA, Tyurina YY, Quinn PJ, Schor NF, Balachandran R, Day BW, Kagan VE. 1998. Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells: Role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. Brain Res Mol Brain Res 60:270-281.
37. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V. 1992. Multiple dopamine D4 receptor variants in the human population. Nature 358:149-152.
38. Welsh GI, Hall DA, Warnes A, Strange PG, Proud CG. 1998. Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors. J Neurochem 70:2139-2146.
39. Whitehouse PJ, Martino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ. 1986. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 644:181-187.
40. Wymann MP, Pirola L. 1998. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436:127-150.
41. Yamashita H, Kawakami H, Zhang YX, Tanaka K, Nakamura S. 1998. Effect of amino acid ergot alkaloids on glutamate transport via human glutamate transporter hGluT1. J Neurol Sci 155:31-36.
42. Zhong LT, Kane DJ, Bredesen DE. 1993. BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res Mol Brain Res 19:353-355.